Remove 2017 Remove Epilepsy Remove Treatment
article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

GW suffers major blow as US sinks bid to patent cannabinoids for epilepsy

Cannabis Law Report

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 5 Reasons Our Double Board Certified Doctor Recommends Marijuana To Patients

LifeCannMD

Fernando Fandiño-Sende in Miami, and is dedicated to the evaluation, education, and treatment of patients who qualify for Medical Cannabis, since June 2017, Florida residents with certain qualifying conditions can obtain a Medical Marijuana recommendation for treatment.

article thumbnail

Answer of the Day for Jul 18, 2022

TheAnswerPage

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2

article thumbnail

Answer of the Day for Jul 19, 2022

TheAnswerPage

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A. 12 September 2018.

article thumbnail

Patient Stories: How MMJ is Changing Lives in West Virginia

MMJ Recs

Cannabis Therapy Impact on West Virginia Patients Medical marijuana was legalized in West Virginia in 2017, and since then, it has been offering a glimmer of hope to many residents suffering from various medical conditions. After starting a medical marijuana treatment plan, her seizures have become less frequent and less severe.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).